BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36344379)

  • 21. [CCAFU french national guidelines 2016-2018 on prostate cancer].
    Rozet F; Hennequin C; Beauval JB; Beuzeboc P; Cormier L; Fromont G; Mongiat-Artus P; Ouzzane A; Ploussard G; Azria D; Brenot-Rossi I; Cancel-Tassin G; Cussenot O; Lebret T; Rebillard X; Soulié M; Renard-Penna R; Méjean A
    Prog Urol; 2016 Nov; 27 Suppl 1():S95-S143. PubMed ID: 27846936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of non-muscle invasive bladder tumours by instillations of mitomycin C and BCG: a survey on French urologists by the French Urological Association].
    Descazeaud A; Mignard JP; Davin JL; Irani J
    Prog Urol; 2009 Oct; 19(9):624-31. PubMed ID: 19800553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.
    Ellis S; Geana M; Griebling T; McWilliams C; Gills J; Stratton K; Mackay C; Shifter A; Zganjar A; Thrasher B
    Trials; 2019 Oct; 20(1):578. PubMed ID: 31590694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
    Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
    Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of social media by French urologists: Results from a study of the National French Urological Association].
    Misrai V; Castagnola C; Descotes JL; Rouprêt M
    Prog Urol; 2015 Jun; 25(7):428-34. PubMed ID: 25921610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [French ccAFU guidelines - update 2020-2022: prostate cancer].
    Rozet F; Mongiat-Artus P; Hennequin C; Beauval JB; Beuzeboc P; Cormier L; Fromont-Hankard G; Mathieu R; Ploussard G; Renard-Penna R; Brenot-Rossi I; Bruyere F; Cochet A; Crehange G; Cussenot O; Lebret T; Rebillard X; Soulié M; Brureau L; Méjean A
    Prog Urol; 2020 Nov; 30(12S):S136-S251. PubMed ID: 33349424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radical prostatectomy for prostate cancer, perioperative management by French urologists in 2018].
    Gas J; Dominique I; Mathieu R; Poinas G; Cuvelier G; Rebillard X; Corbel L;
    Prog Urol; 2020 Sep; 30(10):541-546. PubMed ID: 32646841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of lymph nodes in epidermoid carcinoma of the penis: review of literature by the Committee of Cancerology of the French Association of Urology-External Genital Organs Group (CCAFU-OGE)].
    Marconnet L; Bouchot O; Culine S; Avances C; Rigaud J;
    Prog Urol; 2010 May; 20(5):332-42. PubMed ID: 20471577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Follow-up of urothelial carcinoma: Review of the Cancer Committee of the French Association of Urology].
    Colin P; Neuzillet Y; Pignot G; Rouprêt M; Comperat E; Larré S; Roy C; Quintens H; Houedé N; Soulié M; Pfister C;
    Prog Urol; 2015 Sep; 25(10):616-24. PubMed ID: 26141291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of urologists on clients' demand for screening for prostate cancer in Nigeria.
    Ajape AA; Mustapha K; Lawal IO; Mbibu HN
    Niger J Clin Pract; 2011; 14(2):151-3. PubMed ID: 21860129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)].
    Cormier L; Bastide C; Beuzeboc P; Fromont G; Hennequin C; Mongiat-Artus P; Peyromaure M; Ploussard G; Renard-Penna R; Richaud P; Rozet F; Soulié M; Salomon L;
    Prog Urol; 2014 May; 24(6):334-45. PubMed ID: 24821555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current practice and access to prostate MR imaging in France.
    Renard-Penna R; Rouvière O; Puech P; Borgogno C; Abbas L; Roy C; Claudon M; Correas JM; Cormier L; Ploussard G; Mejean A; Tezenas-du-Montcel S; Rozet F
    Diagn Interv Imaging; 2016 Nov; 97(11):1125-1129. PubMed ID: 27451262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study - GESCAP group.
    Gómez-Veiga F; Rodríguez-Antolín A; Miñana B; Hernández C; Suárez JF; Fernández-Gómez JM; Unda M; Burgos J; Alcaraz A; Rodríguez P; Medina R; Castiñeiras J; Moreno C; Pedrosa E; Cózar JM;
    Actas Urol Esp; 2017; 41(6):359-367. PubMed ID: 28285790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [French ccAFU guidelines - update 2020-2022: management of kidney cancer].
    Bensalah K; Bigot P; Albiges L; Bernhard JC; Bodin T; Boissier R; Correas JM; Gimel P; Hetet JF; Long JA; Nouhaud FX; Ouzaïd I; Rioux-Leclercq N; Méjean A
    Prog Urol; 2020 Nov; 30(12S):S2-S51. PubMed ID: 33349425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort.
    Bolton D; Cheng Y; Willems-Jones AJ; Li J; Niedermeyr E; Mitchell G; Clouston D; Lawrentschuk N; Sliwinski A; Fox S; Thorne H
    BJU Int; 2015 Aug; 116(2):207-12. PubMed ID: 24784491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of the S3 guidelines for early detection of prostate cancer in urological practices].
    Tiedje D; Quer O; Breil B; Schrader AJ; Bothe C; Kruse K; Bögemann M; Donner-Banzhoff N; Semjonow A
    Urologe A; 2017 Jul; 56(7):910-916. PubMed ID: 28280863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.